Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Changes in Clinical Practice After Publication of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Randomized Controlled Trial.

The Journal of the American Academy of Orthopaedic Surgeons·2025
Same author

Association of Cartilage Cap Thickness With Tumor Grade and Outcomes in Secondary Chondrosarcoma.

The Journal of the American Academy of Orthopaedic Surgeons·2025
Same author

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.

Prostate cancer and prostatic diseases·2025
Same author

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Cancer research communications·2025
Same journal

The Algorithm Is Already Scrubbed in and Why Orthopaedic Surgeons Must Lead, Not Follow, the AI Revolution: Commentary on: "Artificial Intelligence in Total Hip and Knee Arthroplasty: A Primer on Current Applications, Algorithms, and Future".

JBJS reviews·2026
Same journal

Beyond the Screw: Commentary on an article by Megna Panchbhavi et al.: "Beyond the Screw: Mapping the Evidence Landscape of Modern Syndesmotic Fixation".

JBJS reviews·2026
Same journal

Immersive Virtual Reality Simulation-Based Assessments in Orthopedic Surgery: A Systematic Scoping Review.

JBJS reviews·2026
Same journal

The Interplay of Diabetes, Glucose Variability, and Antidiabetic Therapy in Preventing Periprosthetic Joint Infection Following Hip and Knee Arthroplasty: A Review.

JBJS reviews·2026
Same journal

How Studying Thresholds Can Harm Health: Commentary on: "Loss of Reduction Following Nonoperative Management for Distal Radius Fractures: A Prognostic Factor Systematic Review and Meta-Analysis".

JBJS reviews·2026
Same journal

Clinically Significant Changes in Global Cervical Range of Motion Following Anterior Cervical Discectomy and Fusion: A Systematic Review.

JBJS reviews·2026
See all related articles

Related Experiment Video

Updated: Jul 8, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K

Team Approach: Extremity Soft Tissue Sarcoma.

Carol D Morris1, Lauren B Banks2, Valerie A Fitzhugh3,4

  • 1Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, New York.

JBJS Reviews
|December 20, 2023
PubMed
Summary
This summary is machine-generated.

Synovial sarcoma, a soft tissue tumor, often appears near joints in extremities. Orthopedic surgeons must suspect this cancer in patients with extremity masses due to overlapping symptoms with non-oncologic conditions.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Related Experiment Videos

Last Updated: Jul 8, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Area of Science:

  • Orthopedic Oncology
  • Soft Tissue Pathology

Background:

  • Synovial sarcoma is a type of soft tissue sarcoma.
  • It commonly occurs in the extremities, near joints.
  • Clinical presentation can mimic benign orthopedic conditions.

Purpose of the Study:

  • To highlight the importance of high clinical suspicion for synovial sarcoma in orthopedic practice.
  • To emphasize the need for prompt diagnosis and referral for soft tissue masses.

Main Methods:

  • Review of clinical presentation and diagnostic challenges of synovial sarcoma.
  • Discussion of differential diagnoses for extremity masses.

Main Results:

  • Synovial sarcoma symptoms can overlap significantly with non-oncologic orthopedic issues.
  • High index of suspicion is critical for early detection.

Conclusions:

  • Orthopedic surgeons should maintain a high level of suspicion for synovial sarcoma in patients with extremity masses.
  • Early recognition and referral to a multidisciplinary sarcoma team are essential for optimal patient outcomes.